Sensus Healthcare reports a 127% revenue jump to $8.8M in Q3 2024, fueled by radiotherapy sales.

Sensus Healthcare, a medical device company, saw its revenue surge 127% to $8.8 million in Q3 2024, up from $3.9 million last year, due to increased sales of their superficial radiotherapy systems. The company has signed 22 revenue-sharing agreements since March, with plans to reach over 50 by year-end. Sensus ended the quarter with $22.6 million in cash and no debt, indicating strong financial health.

November 18, 2024
3 Articles